TRE Holdings Corp
TSE:9247
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
TRE Holdings Corp
TSE:9247
|
JP |
|
F
|
Fennec Pharmaceuticals Inc
TSX:FRX
|
US |
Cash Flow Statement
Cash Flow Statement
TRE Holdings Corp
| Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||
| Net Income |
7 738
|
6 006
|
9 325
|
19 194
|
25 593
|
|
| Depreciation & Amortization |
6 363
|
6 466
|
7 172
|
8 593
|
9 371
|
|
| Other Non-Cash Items |
(91)
|
1 893
|
2 004
|
3 383
|
3 670
|
|
| Cash Taxes Paid |
2 469
|
2 042
|
2 195
|
2 321
|
7 152
|
|
| Cash Interest Paid |
298
|
337
|
418
|
523
|
599
|
|
| Change in Working Capital |
(2 609)
|
(2 169)
|
(11 523)
|
(11 335)
|
(8 862)
|
|
| Cash from Operating Activities |
11 401
N/A
|
12 196
+7%
|
6 978
-43%
|
19 835
+184%
|
29 772
+50%
|
|
| Investing Cash Flow | ||||||
| Capital Expenditures |
(8 350)
|
(11 958)
|
(12 278)
|
(11 960)
|
(15 776)
|
|
| Other Items |
(4 621)
|
(4 861)
|
46
|
(122)
|
(1 967)
|
|
| Cash from Investing Activities |
(12 971)
N/A
|
(16 819)
-30%
|
(12 232)
+27%
|
(12 082)
+1%
|
(17 743)
-47%
|
|
| Financing Cash Flow | ||||||
| Net Issuance of Common Stock |
(2)
|
(2)
|
(1 332)
|
(4 400)
|
(3 473)
|
|
| Net Issuance of Debt |
694
|
3 854
|
8 551
|
7 855
|
2 003
|
|
| Cash Paid for Dividends |
(2 078)
|
(2 088)
|
(2 088)
|
(2 072)
|
(2 267)
|
|
| Other |
25
|
(155)
|
(56)
|
123
|
(78)
|
|
| Cash from Financing Activities |
(1 361)
N/A
|
1 609
N/A
|
5 075
+215%
|
1 506
-70%
|
(3 815)
N/A
|
|
| Change in Cash | ||||||
| Net Change in Cash |
(2 931)
N/A
|
(3 014)
-3%
|
(179)
+94%
|
9 259
N/A
|
8 214
-11%
|
|
| Free Cash Flow | ||||||
| Free Cash Flow |
3 051
N/A
|
238
-92%
|
(5 300)
N/A
|
7 875
N/A
|
13 996
+78%
|
|